Breaking Barriers: Advancing Intranasal Drug Delivery for Central Nervous System Disorders

作者
Rajeev Kumar,Ajaypal Singh,Sanjar Alam
出处
期刊:Current Pharmacogenomics and Personalized Medicine [Bentham Science Publishers]
卷期号:23
标识
DOI:10.2174/0118756921431009260804093539
摘要

Abstract: The Blood-Brain Barrier (BBB) poses a significant obstacle to the delivery of therapeutic agents to the Central Nervous System (CNS), complicating treatment for neurological disorders such as Alzheimer's, Parkinson's, and epilepsy. Intranasal (IN) delivery has emerged as a promising non-invasive method to bypass the BBB, utilizing the nasal cavity's unique anatomy to achieve direct drug transport to the brain. This route minimizes systemic side effects and avoids first-pass metabolism. Key mechanisms include transport via the olfactory and trigeminal nerves, facilitating rapid and efficient delivery of small, lipophilic, and nanoparticle-encapsulated drugs. Recent advancements in nanotechnology have enhanced IN drug delivery, offering improved bioavailability, targeting specificity, and prolonged residence time in the nasal mucosa. Nanoparticles such as lipid carriers and polymer-based systems have demonstrated potential in overcoming mucociliary clearance, enzymatic degradation, and tight junction barriers. Furthermore, innovative delivery devices, including atomizers and pressurized systems, have optimized deposition in the olfactory region, increasing therapeutic efficacy. Challenges remain, including limited nasal cavity volume, formulation stability, and variability in patient anatomy. Strategies such as permeation enhancers, mucoadhesive agents, and enzyme inhibitors are under investigation to mitigate these barriers. Preclinical and clinical studies highlight the potential of IN delivery systems in revolutionizing CNS treatment by providing targeted, efficient, and less invasive therapeutic options. This paper reviews recent developments, focusing on the application of nanoparticle-based formulations for nose-to-brain drug delivery, underscoring their promise in addressing unmet clinical needs.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
隐形曼青的应助被科研通管家采纳,获得10
刚刚
crity完成签到,获得积分10
刚刚
调皮钧发布了新的文献求助10
刚刚
刚刚
李爱国的应助被科研通管家采纳,获得10
刚刚
刚刚
Owen的应助被科研通管家采纳,获得10
刚刚
fantasy的应助被科研通管家采纳,获得10
刚刚
Akim的应助被科研通管家采纳,获得10
刚刚
传奇3的应助被Wenyilong采纳,获得10
刚刚
Lucas的应助被科研通管家采纳,获得10
刚刚
田様的应助被15331970326采纳,获得10
刚刚
赘婿的应助被科研通管家采纳,获得10
刚刚
嘻嘻哈哈的应助被科研通管家采纳,获得10
1秒前
英姑的应助被科研通管家采纳,获得10
1秒前
John的应助被科研通管家采纳,获得10
1秒前
科研通AI65的应助被科研通管家采纳,获得10
1秒前
英姑的应助被科研通管家采纳,获得10
1秒前
1秒前
王帅崽发布了新的文献求助10
1秒前
学术大佬完成签到 ,获得积分10
2秒前
学术圈的泥石流完成签到 ,获得积分10
2秒前
OK发布了新的文献求助10
2秒前
李健的应助被踏实的伟帮采纳,获得10
2秒前
2秒前
2秒前
Zephyr完成签到,获得积分10
2秒前
空白发布了新的文献求助10
3秒前
4秒前
负责念梦发布了新的文献求助10
4秒前
gaoyi12356完成签到,获得积分10
5秒前
望泞完成签到,获得积分10
5秒前
黄毛虎发布了新的文献求助10
5秒前
呆呆的笨石头完成签到,获得积分10
5秒前
rain发布了新的文献求助10
5秒前
5秒前
Zephyr发布了新的文献求助10
5秒前
聪明藏今完成签到,获得积分10
5秒前
入司的应助被无为采纳,获得10
6秒前
7秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
八旗制度の研究 600
高分子基功能界面水蒸发材料与应用研究 500
外场增强的水汽发电研究 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8187480
求助须知:如何正确求助?哪些是违规求助? 9575554
关于积分的说明 21841909
捐赠科研通 7785230
什么是DOI,文献DOI怎么找? 3434949
关于科研通互助平台的介绍 2559412
邀请新用户注册赠送积分活动 2481898